Researchers of The Commonwealth Fund discovered that 95% of individuals with Medicaid coverage over the past year had a regular doctor and 55% of this population reported receiving excellent or very good care.
Researchers of The Commonwealth Fund discovered that 95% of individuals with Medicaid coverage over the past year had a regular doctor and 55% of this population reported receiving excellent or very good care. These numbers mirrored what the researchers found when studying the individuals with private insurance—53% of the privately insured population who also had a regular doctor reported good care.
However, only three-quarters of the individuals who were either uninsured during the past year or experienced a time period without coverage reported to have regular doctors and even less of this population claimed to have received good care.
The researchers examined the Commonwealth Fund Biennial Health Insurance Survey, 2014, for their report, studying and comparing the responses of adults aged 19 to 64 years who were either enrolled in Medicaid coverage, a private insurance plan, or who were not insured at all. The report controlled for differences in numerous variables including income, race, and gender in order to adequately assess the effects of healthcare coverage.
“Medicaid provides millions of Americans with health insurance, and it is important to track how that insurance is working for them,” Sara Collins, Vice President for Health Care Coverage and Access at The Commonwealth Fund, said in a statement. “These results indicate that on many measures Medicaid works nearly as well as, and sometimes better, than private insurance and is helping people get and afford the care they need.”
In addition to examining patient-reported experiences, the report analyzed preventive-care measures and cost-related access issues among the 3 populations of health coverage.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More